Difference between revisions of "Schmoll D"
From Bioblast
(Created page with "{{Person |lastname=Schmoll |firstname=Dieter |title=Dr. |[email protected] |address=Sanofi-Aventis Deutschland GmbH R&D TD Metabolism FFM Industri...") |
Beno Marija (talk | contribs) |
||
| (4 intermediate revisions by 3 users not shown) | |||
| Line 3: | Line 3: | ||
|firstname=Dieter | |firstname=Dieter | ||
|title=Dr. | |title=Dr. | ||
|institution=Sanofi-Aventis Deutschland GmbH | |||
R&D | R&D DIAB Div. / Innovation&ext.Network. FF | ||
|address=Industriepark Hoechst | |||
Bldg. H825, Room 243 | |||
|area code=65926 | |||
|city=Frankfurt am Main | |||
|country=Germany | |||
|weblink=www.sanofi.de | |||
}} | |||
{{Labelingperson}} | |||
== Participated at== | |||
::::* [[IOC54|IOC54 Schroecken AT]] | |||
Latest revision as of 16:45, 12 February 2018
| Name | Schmoll Dieter, Dr. |
|---|---|
| Institution | Sanofi-Aventis Deutschland GmbH
R&D DIAB Div. / Innovation&ext.Network. FF |
| Address | Industriepark Hoechst
Bldg. H825, Room 243, 65926 |
| City | Frankfurt am Main |
| State/Province | |
| Country | Germany |
| [email protected] | |
| Weblink | www.sanofi.de |
| O2k-Network Lab | DE Frankfurt Schmoll D |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Karusheva 2019 Am J Clin Nutr | 2019 | Karusheva Y, Koessler T, Strassburger K, Markgraf D, Mastrototaro L, Jelenik T, Simon MC, Pesta D, Zaharia OP, Bódis K, Bärenz F, Schmoll D, Wolkersdorfer M, Tura A, Pacini G, Burkart V, Müssig K, Szendroedi J, Roden M (2019) Short-term dietary reduction of branched-chain amino acids reduces meal-induced insulin secretion and modifies microbiome composition in type 2 diabetes: a randomized controlled crossover trial. Am J Clin Nutr 110:1098-107. |
